Background: Permanent pacemaker implantation is a minimally invasive surgical procedure in the management of patients with cardiac rhythm disturbances. Previous studies have reported gender differences in pacemaker selection. There is lack of evidences in selection of pacemaker mode with respect to gender in Nepal. Therefore, this study was performed to compare the frequency of implantation between men and women.
Introduction
Permanent pacemaker implantation is one of the most common therapeutic or prophylactic strategies in the management of patients with cardiac problems at present. 1 The basic function of the pacemaker is to pace the heart in the absence of intrinsic impulses, and to recognize intrinsic cardiac electrical activity if present and restrain pacing consequently. Optimal selection of the single or dual chamber pacemaker devices depend in terms of arrhythmia, their cost effectiveness and longevity. 2 However, considerable differences have been reported in the frequency of implantation of pacemakers and in the system selected. 3, 4 Gender differences are increasingly recognized in medicine and especially in cardiology. From previous studies, it is known, for example, that women have a higher likelihood for complications and a higher mortality related to coronary revascularization procedures. In arrhythmias, gender-specific variations in the electrophysiological structure of the heart or hormonal effects may explain some of the gender differences. 8 and deep vein thrombosis (DVT). 9 Likewise, information related to prominent symptoms such as syncope and palpitation, and major indications like complete heart block (CHB), sick sinus syndrome (SSS) and symptomatic high degree Atrioventricular (AV) block were also noted. Permanent pacemaker implantations were performed in a fluoroscopic C arm equipped theatre. The implantation team consisted of a consultant who performed the implantation, Doctor of Medicine (DM) resident posted in cardiac catheterization laboratory, a cardiac physiologist who checked the pacemaker parameters, a pacemaker technician to operate the fluoroscope for imaging and a scrub nurse. After implantation, patients were closely monitored on the ward for 48 hours. Data were compiled, edited and checked to maintain consistency prior to coding and entering in Epidata V.2.1 and exporting to SPSS V. 16 .0 for further analysis. For inferential statistics, chi-square and t tests were conducted to compare the proportions of categorical and mean of continuous variables respectively. A p value of less than 0.05 was considered statistically significant.
Results
The baseline characteristics are presented in table 1. The mean (SD) age of total population at implant was 64.08 ± 15.09 years. Mean age of patients who received dual chamber pacemaker was 64.92 ± 13.20 years, not significantly different from those received single chamber pacemaker (65.80 ± 12.81 years, P = 0.80). During the study period, a total of 54 women (48.27%) received pacemakers. Overall the mean age of women at pacemaker implantation was not significantly different from the age of men (63.2 years ± 11.3 vs 65.0 years ± 12.4, P= 0.37). Dual chamber units were implanted in 44 (37.93%) of patients, single chamber in 72 (62.06%). Only 14 women (12.06%) received dual chamber compared with 42 women (36.20%) who received single chamber (Chisquare=18, DF=1, P = 0.0084). Following hypertension and CKD, LV dysfunction was present in 7.75% of total patients in dual chamber and 12.93% of total patients in single chamber. Diabetes mellitus was present in 4.31% in dual chamber and 7.75% in single chamber. Similarly, CAD was present in 3.44% in dual chamber and 4.31% in single chamber. Two (1.72% of total 116 patients) out of total five patients with COPD, were in dual chamber and three (2.58% of total patients) were in single chamber. DVT was present in two patients in single chamber and none in dual chamber. Univariate analysis of demographic and clinical variables on selection of permanent pacemaker implantation was performed ( Table 2) . Women were more likely to receive single chamber systems and less likely to receive dual chamber systems than men (Odds ratio:3.593; 95% confidence interval:1.101-11.732; p < 0.001).
Discussion
Our study was undertaken to evaluate influence of gender on selection of permanent pacemaker mode. Analysis of data from 116 patients suggests a sex bias in choice of a pacemaker system. Women were more likely to receive single chamber systems and less likely to receive dual chamber than men. Can these findings be explained by differences in the underlying cardiac disorders or demographic data? Doctors generally implant single chamber pacemakers in elderly patients rather than dual chamber systems. Several studies of factors influencing cardiovascular interventions showed that sex was no longer a determinant once demographic and clinical variables had been adjusted for. 10 Our results agree with two retrospective studies in the United States in which women were found to receive a dual chamber system less frequently than men. 11 The clinical importance of the suggested undertreatment of women with dual chamber pacemakers is not easy to evaluate. Dual chamber pacemakers have been shown to offer haemodynamic advantages over single chamber pacemaker. 12 Although there is evidence that patients treated by advanced pacing have a better quality of life, it is not known whether this improvement is equal in men and women. What other reasons could there be for doctors deciding in favour of a single chamber pacemaker in women? Firstly, there are some "soft" indications for implanting pacemakers (class II indications in the American College of Cardiology/American Heart Association guidelines). Doctors are known to behave differently towards men and women as far as both diagnostic and therapeutic strategies are concerned. 13 Doctors seeing women with "soft" indications may tend to implant single chamber pacemakers whereas they choose dual chamber for men. Some of the "hard" indications may also be being neglected in women. Women often present their symptoms differently from men.
14 They are more likely to receive the same treatment as men if they present their symptoms as men do. 15 Finally, we found some published evidence that women sometimes reject sophisticated care in favour of more simple treatments. They may therefore choose not to have dual chamber systems. 16 Since the implantation of the first artificial pacemaker in 1958 these devices have become the treatment of choice in bradycardias. 17 There are two often related reasons for implanting a cardiac pacemaker: to relieve symptoms and to improve survival. Most patients treated with pacemaker implantation are elderly persons with either chronic atrioventricular-block (AVB) or sick sinus syndrome (SSS). 18 Permanent pacing for complete heart block was the commonest indication in this study (56.03%) and it was comparable (42%) to that reported from a similar population. Untreated complete heart block has a one year and five year mortality of 50% and 75%-90% respectively; while survival is 70%-85% at five years in those paced. 19 Sick sinus syndrome was responsible for 33.62% of patients paced in this report and it was identical to that reported from a similar district general population in UK. Pacing for sick sinus syndrome is based on the association of symptoms with specific dysrrhythmia5; it effectively relieves symptoms of bradycardia and can facilitate more aggressive drug treatment of tachyarrhythmias, 20 but there is no evidence that pacing asymptomatic patients improves prognosis.
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Conclusions
Women were more likely to receive single chamber systems and less likely to receive dual chamber systems than men. Future prospective studies on larger number of patients are needed to confirm and support our findings.
